Arcturus Therapeutics Holdings Inc (ARCT)

Cost of Revenue

$4.00M

TTM · Period ending: · USD

ARCT logo

ARCT Cost of Revenue

Latest reported$4.00M
ARCT TTM Cost of Revenue ($0.00 → $4.00M)
High-resolution chart · PNG

ARCT cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arcturus Therapeutics Holdings Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
4,000,000
4,000,000
3,342,000
3,342,000
0
0
0
0
0
3,741,000
55,509,000
82,490,000
120,178,000
154,626,000
147,751,000
151,503,000
159,213,000
166,703,000
171,860,000
163,513,000
118,115,000
72,436,000
22,386,000
11,994,000
19,047,000
26,316,000
33,640,000
26,493,000
23,409,000
20,365,000
16,982,000
16,488,000
16,082,000
15,626,000
15,686,000
11,333,000
7,770,000
4,001,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.